Delivery Order SPE2DB22D1017-SPE2DB24FF7JF

Award Date 5/8/24
Potential Completion Date 5/9/24
Potential Value $8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award with ID SPE2DB20D2014|SPE2DB23FC20Y was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $32,190.56 firm fixed price delivery order is for the supply of Eliquis 5 mg tablets. The award has an ultimate completion date of May 12, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government...
This federal contract award, with ID SPE2DB20D2200|SPE2DB24FW97B, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $12,414.65, is for the delivery of Eliquis 5 mg tablets. This is a firm fixed-price delivery order contract with an ultimate completion date of August 9, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $11,372.01, is a Firm Fixed Price Delivery Order for the procurement of Eliquis 5 mg tablet 60 count. The contract has an ultimate completion date of January 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products to federal government agencies,...
This federal contract award, valued at $91,560.21, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Eliquis 5 mg tablets, a pharmaceutical product used for various medical conditions. The contract has a period of performance through February 26, 2025 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
This federal contract award, with ID SPE2DX15D2205|SPE2DX24F74DU, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $49,385.92 firm-fixed-price delivery order is for the supply of Eliquis 5 mg tablets. The contract has an ultimate completion date of November 13, 2023 and was awarded on November 9, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a...
This federal contract award, with ID SPE2DB20D3304|SPE2DB24FW6Q5, was granted by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award, valued at $6,694.00, is for the delivery of Eliquis 5 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of July 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides critical medical products and supplies to federal government agencies,...
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FETR1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $58,877.94 firm fixed price delivery order is for the supply of Eliquis 5 mg tablets. The contract has an ultimate completion date of May 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, with an ID of SPE2DB20D2104|SPE2DB24FU80C, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,206.26, is for the delivery of Eliquis 5 mg tablets. It is a firm fixed-price delivery order contract with a period of performance through June 24, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award, with ID SPE2DB22D1106|SPE2DB25FECZ8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Eliquis 5 mg tablets in quantities of 60 per package. The award has a ceiling value of $29,589.07 and a completion date of March 14, 2025. This contract is a delivery order with a firm fixed price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award, with ID SPE2DB22D2006|SPE2DB24FV7LM, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $51,942.36 and is for the delivery of Eliquis 5 mg tablets. It is a Firm Fixed Price delivery order contract with a completion date of January 17, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FF7JF
    Delivery Order

This federal contract award, with ID SPE2DB22D1017|SPE2DB24FF7JF, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award, valued at $7,978.11, is for the delivery of Eliquis 5 mg tablets. The contract has a completion date of May 9, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a for-profit pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/16/25, 12:37 PM